What you need to know about the highly contagious delta variant

What you need to know about the highly contagious delta variant

The variant first identified in India last year is now dominant in the United States

A woman receives Russia’s Sputnik V vaccine in Moscow, amid spiraling covid-19 cases from the delta variant. (Yuri Kochetkov/EPA-EFE/Shutterstock)By Lindsey Bever and Joel Achenbach July 9, 2021 at 11:03 a.m. EDT

The highly transmissible coronavirus variant called delta is present in all 50 states and is already dominant in many parts of the United States.

Modeling shows the variant now accounts for 51.7 percent of all new infections in this country, five times the prevalence four weeks earlier, according to data from the Centers for Disease Control and Prevention for the week ending July 3.

“Although we expected the delta variant to become the dominant strain in the United States, this rapid rise is troubling,”

CDC Director Rochelle Walensky said Thursday during a White House news briefing.

In some parts of the country, she said, delta is even more widespread. For example, in parts of the Midwest and upper mountain states, including in Missouri, Nebraska, Kansas, and Iowa, the CDC’s sequencing of infections suggests the new variant may account for about 80 percent of cases.

The good news, Walensky said, is all three coronavirus vaccines authorized in the United States offer strong protection against severe disease and death from covid-19. Preliminary data from several states over the past several months suggests that 99.5 percent of covid-19-related deaths occurred among unvaccinated people, she said.

Here are answers to commonly asked questions about the delta variant and how to protect yourself.

Frequently Asked Questions

  • What is the delta variant?
  • Why is the delta variant a concern?
  • How effective are the vaccines against the variant?
  • How will the delta variant affect the United States?
  • Do symptoms from delta infections differ from infections from other variants of the coronavirus?
  • Will booster shots be needed?

What is the delta variant?

The delta variant, also known as B. 1.617, was first detected last year in India, where it has been ravaging the nation and has since spread to dozens of other countries, upending plans for a return to normalcy.

Delta has several lineages with slightly different sets of mutations. One of those — B. 1.617.2 — is also now the dominant coronavirus variant in the United Kingdom, where it accounts for the vast majority of all covid-19 cases in that nation.

You had the Johnson & Johnson coronavirus vaccine. Should you try to get a booster dose of Pfizer or Moderna?

Health experts describe delta as the most “fit” variant of the coronavirus. That means it’s likely to outcompete other variants to infect more people with covid-19, the disease caused by the virus, said Monica Gandhi, an infectious disease expert at the University of California at San Francisco. “It’s the one that is most likely to latch onto cells in a host, and it attacks that host better than the other variants because it can replicate itself better.” The delta variant is causing outbreaks across the U.S. Here’s how we beat it. The delta variant has become the dominant strain of coronavirus in the United States resulting in a rise in infections and hospitalizations. (John Farrell/The Washington Post)

Why is the delta variant a concern?

Early research suggests the delta variant is about 50 percent more contagious than the alpha variant, which was first identified in the United Kingdom and became the predominant variant in the United States during the spring. Alpha was already about 50 percent more transmissible than the original variant of the coronavirus first identified in Wuhan, China, in late 2019.Advertisement

Although there is compelling evidence that delta is more transmissible, there is limited data on whether it is more likely to result in a severe illness.

Public Health England (PHE) found that the variant may be associated with a higher risk of hospitalization, and some early research from Scotland suggests that the risk of hospitalization with covid-19 from the delta variant is about twice the risk from the alpha variant — with unvaccinated people at the greatest risk.

But health experts caution that there is not yet conclusive evidence that delta causes more severe disease. Hospitals serving areas where it is surging have reported admitting more young and middle-aged covid-19 patients, but that may be because they are less likely to be vaccinated.

How effective are the vaccines against the variant?

Real-world data suggest that all three vaccines authorized for emergency use by the Food and Drug Administration offer strong protection against severe disease and death from the delta variant, although they appear tooffer less robust protection against minor to moderate infections.

Such data has come not only from the United States but also from other countries.

“I think this is a really important point because that’s our primary goal with our vaccination effort: to prevent severe disease, to prevent hospitalization, to prevent deaths,” said William Moss, a professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health.

In the case of the two-dose messenger RNA vaccines, both shots are needed to mount a strong response against the delta variant. Research from PHE showed that the Pfizer-BioNTech vaccine was 33 percent effective against symptomatic infection from delta after the first shot of the two-shot regimen, but 88 percent effective after the second.

In terms of preventing hospitalizations from the delta, another PHE paper suggested that the Pfizer vaccine was 94 percent effective after the first shot and 96 percent effective after the second.

Health experts said that, because the Moderna vaccine uses the same technology as the one from Pfizer, they extrapolate that it offers similar protection.

As for the Johnson & Johnson shot, one small study showed that people who took the vaccine mounted a strong antibody response against the variant, the company told The Washington Post.

Some researchers believe the Johnson & Johnson vaccine may end up showing similar results to the AstraZeneca vaccine, which was included in the PHE studies and found to be 60 percent effective against symptomatic disease and 92 percent effective against hospitalization after both doses. The AstraZeneca vaccine has not been approved for use in the United States.

“The good news is that our vaccinations are highly effective,” President Biden recently said. “Fully vaccinated Americans have a high degree of protection, including against this delta variant.”

The president said the rapid spread of a more easily transmissible and potentially more dangerous variant “should cause everybody to think twice.”

He added: “And it should cause reconsideration, especially in young people who may have thought that they didn’t have to be vaccinated, didn’t have to worry about it, didn’t have to do anything about it up to now.”

How will the delta variant affect the United States?

With more than 150 million Americans now fully inoculated against the coronavirus, the delta variant is not expected to cause massive outbreaks across the entire United States. Instead, health experts anticipate that it will cause surges in communities where vaccination rates are lower, posing the most serious risk to those who are older, sicker, and unvaccinated.

“We’re going to have to face it throughout the United States,” said Eric Topol, a professor of molecular medicine and executive vice president at Scripps Research. “So far, it’s at a low level in terms of increase in cases, but we don’t know where it’s headed.”

Topol said delta is already spreading through states such as Nevada, Missouri, Arkansas, Utah, and Wyoming, which are more vulnerable because they have had fewer coronavirus cases and lower vaccination rates, meaning they do not have as much natural and vaccine-induced immunity.

States with higher vaccination rates, such as Connecticut, Massachusetts and Vermont, have “a delta wall,” he said.

Anthony S. Fauci, the nation’s leading infectious disease expert, recently said he is “very concerned” about the variant because it could lead to “two Americas”: one largely protected because of high vaccination rates, the other experiencing surges because of low vaccination rates.

“When you have such a low level of vaccination superimposed upon a variant that has a high degree of efficiency of spread, what you are going to see among under-vaccinated regions — be that states, cities, or counties — you’re going to see these individual types of blips. It’s almost like it’s going to be two Americas,” he said.

Coronavirus infections dropping where people are vaccinated, rising where they are not, Post analysis finds

Do symptoms from delta infections differ from infections from other variants of the coronavirus?

There is little research on this, but some people have reported symptoms such as a headache, sore throat, and runny nose, without the hallmark covid-19 signs, such as a loss of taste and smell.

Will booster shots be needed?

That is an open question. Federal health officials are not recommending them at this time but at least one of the vaccine makers said it plans to seek approval for a booster shot.

Data released this week by the Israel Ministry of Health showed waning vaccine efficacy against the coronavirus in that highly vaccinated country as the delta variant became more widespread. The small study, which has not yet been published, showed vaccinated people retained protection against severe disease and hospitalization, but had markedly lower protection against infection and symptomatic illness.

Citing that data, Pfizer and its partner BioNTech released a statement July 8 saying they would seek federal regulatory approval for a booster shot following studies that found such a shot caused disease-blocking antibodies to increase five to 10 times higher than after the two-shot regimen. “[We continue to believe that it is likely, based on the totality of the data we have to date, that a third dose may be needed within six to 12 months after full vaccination,” the statement said.

But hours later, the Department of Health and Human Services issued a rebuke, saying “Americans who have been fully vaccinated do not need a booster shot at this time.”

The HHS statement said “a science-based, rigorous process” headed by the Centers for Disease Control and Prevention, the Food and Drug Administration and the National Institutes of Health would determine when or whether boosters were necessary.

What else can people do to protect themselves?

Health experts say that people who are not yet vaccinated should continue to wear masks and make plans to get vaccinated as soon as they can.

While the CDC no longer recommends masking for those who are fully vaccinated, because the vaccines provide a high degree of protection, Fauci said individuals may make their own assessments of risk based on their age, health status and circumstances.

Those living in areas where vaccination rates are low and delta cases are high may want to continue covering their faces, particularly in high-risk settings, such as indoor gatherings, areas with large crowds or places such as senior living facilities, where the consequences of transmission could be grave.

The World Health Organization is still urging people around the world to mask up. Mariângela Simão, the WHO’s assistant director-general for access to medicines and health products, recently told reporters: “People cannot feel safe just because they had the two doses. They still need to protect themselves.”

Gandhi said that recommendation makes sense coming from the WHO, which is dealing with very mixed populations across the globe, many with high amounts of circulating virus, low vaccination rates, and less effective vaccines. Only about 11 percent of the world’s population has been fully inoculated against the virus.

“The likelihood of getting a breakthrough infection with any variant is not just dependent on your vaccination status but the amount of virus you’re seeing circulating in your community,” she said. “It’s why health-care workers in India, even though they were fully vaccinated, still had breakthrough infections, because they were seeing so much virus.”

Health experts also urge vaccinated people to get tested for the coronavirus if they experience any symptoms related to the illness to rule out potential breakthrough infections and to seek treatment if they test positive.

What about people who are immunocompromised?

Vaccination is still the top recommendation to protect against the virus, including the delta variant, although not all immunocompromised people may mount a robust response. But others will build immunity from the shots, and there appears to be no harm from getting immunized, said William Schaffner, medical director of the National Foundation for Infectious Diseases.

Beyond that, individuals with compromised immune responses should practice social distancing, wear masks and avoid crowds, particularly indoors. “Those things continue to pertain to these highly susceptible people,” he said.

Schaffner, a professor of infectious diseases and preventive medicine at Vanderbilt University, said it’s also important for immunocompromised people to get tested if they experience symptoms, especially as the new influenza season rolls around, so they can get treated appropriately — either for flu or covid-19. In some cases, for example, antiviral medications may be used to treat influenza and monoclonal antibodies may be used to treat covid-19, which can reduce the risk of hospitalization and death when used early in the course of the disease.

What about the risk to children, and how can parents protect them?

There is no indication the delta variant is more virulent if it infects children, said Paul A. Offit, a pediatrician and the director of the Vaccine Education Center at Children’s Hospital of Philadelphia.

However, because delta is more contagious than earlier variants, children are at somewhat greater risk of infection. Those who are 12 and older are eligible for vaccines, and federal health officials recommend they be immunized for greater protection.

Should my child get a coronavirus vaccine? Is it safe? Here’s what you should know.

Offit suggests parents make sure that unvaccinated children ages 2 or older, if not eligible for the vaccines, wear masks if they are in public spaces indoors, in accord with CDC guidance.

The CDC also recommends that parents make sure their unvaccinated children wash their hands often with soap and water, avoid close contact with those who are coughing, sneezing, or complaining of feeling unwell, and limit interactions with people who are at high risk of developing severe disease.

The bottom line is that people need to take measures to protect themselves and their loved ones against the delta variant.

“If you haven’t had covid, you’re not vaccinated and you’re not wearing a mask, you’re basically asking for delta trouble. It’ll find you. It’s the most efficient form of the virus for finding hosts, by far. If you’re not vaccinated, a mask is important right now,” Topol said.

Ben Guarino contributed to this report.Updated June 23, 2021

By Lindsey BeverLindsey Bever is a general assignment reporter for The Washington Post, covering national news with an emphasis on health. She was previously a reporter at the Dallas Morning News. Twitter

By Joel AchenbachJoel Achenbach covers science and politics for the National desk. He has been a staff writer for The Post since 1990. Twitter

Leave a Reply

HTML Snippets Powered By : XYZScripts.com